China Fortune Financial News App reports that Cathay Biotech Inc. (688065.SH) disclosed its third quarter report for 2024. The company achieved revenue of 2.215 billion yuan in the first three quarters, a year-on-year increase of 41.49%. The net income attributable to shareholders of the listed company was 0.345 billion yuan, a year-on-year increase of 9.97%. The net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 0.335 billion yuan, a year-on-year increase of 25.51%. The basic earnings per share is 0.59 yuan per share.